0001181431-13-040876.txt : 20130719
0001181431-13-040876.hdr.sgml : 20130719
20130719185837
ACCESSION NUMBER: 0001181431-13-040876
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20130717
FILED AS OF DATE: 20130719
DATE AS OF CHANGE: 20130719
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: OncoMed Pharmaceuticals Inc
CENTRAL INDEX KEY: 0001302573
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 383572512
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 800 CHESAPEAKE DRIVE
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
BUSINESS PHONE: 650-995-8200
MAIL ADDRESS:
STREET 1: 800 CHESAPEAKE DRIVE
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: HASTINGS PAUL J
CENTRAL INDEX KEY: 0001309702
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35993
FILM NUMBER: 13977899
MAIL ADDRESS:
STREET 1: 61 HARTFORD STREET
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94114
4
1
rrd386069.xml
X0306
4
2013-07-17
0
0001302573
OncoMed Pharmaceuticals Inc
OMED
0001309702
HASTINGS PAUL J
C/O ONCOMED PHARMACEUTICALS, INC.
800 CHESAPEAKE DRIVE
REDWOOD CITY
CA
94063
1
1
0
0
President & CEO
Stock Option (right to buy)
17.00
2013-07-17
4
A
0
160000
0
A
2023-07-17
Class A Common Stock
160000
160000
D
The shares subject to the option vest in 48 successive, equal monthly installments on each monthly anniversary of July 17, 2013, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date.
The Class A Common Stock will be redesignated "Common Stock" immediately prior to the consummation of the Issuer's initial public offering.
/s/ Yvonne Li, Attorney-in-Fact for Paul Hastings
2013-07-19